UnitedHealth Downgraded


An analyst downgraded UnitedHealth Group Inc. (NYSE: UNH) citing unrealistic Medicare reimbursement goals to boost profits sending the stock price down $1.91 to $23.82.

About this Entry

This page contains a single entry by published on June 11, 2009 10:43 AM.

Positive Trial Results For Human Genome was the previous entry in this blog.

Staar Surgical's Injector System Approved is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12